ABSTRACT

Abstracts submission

Congress delegates are cordially invited to submit abstracts of their scientific work for presentation at the IFCC WorldLab New Delhi 2026 Congress.

An unlimited number of abstracts may be submitted provided the presenting author applies for “full

registration” or “young registration” (no “daily registration” allowed).

Abstracts are welcome in all fields of clinical chemistry, haematology, clinical molecular biology and laboratory medicine, in the broader sense. Abstracts will primarily be presented via poster. A limited number of abstracts will be selected also for oral presentation during congress symposia. Authors wishing to compete for these oral communication slots should mark the appropriate field on the on-line abstract-submission form.

Deadline for abstract submission

15th May 2026, 18:00 CET

General requirements

The text must be clear, concise, and written in proper English. The content must not have been previously published in academic journals or subject to peer review. Significant technical information must not be withheld. Abstracts must absolutely contain results. Statements such as “results will be discussed” are not acceptable and will lead to rejection.

General information

Deadline for receipt

Abstracts should be submitted by 15th May 2026, 18:00 CET.

Confirmation of receipt

Receipt of the abstract will be acknowledged by e-mail immediately after submission.

Notification of acceptance or rejection

Authors will be notified of acceptance or rejection within 30th June 2026.

Registration

The presenting author of each abstract must register for the congress with “Full Registration” or “Young Registration”.

IMPORTANT: when submitting the abstract, please make sure to indicate as presenting author the person who will register and attend the Congress (no other authors). The presenting author cannot be modified after the submission.

How to prepare and submit an abstract

It is important to carefully follow the instructions below. Incorrectly prepared abstracts will be rejected.

  • Abstracts should be prepared off-line in advance;
  • Prepare your abstract on a word processor (such as Microsoft Word);
  • Do not include title, authors’ names and affiliations in the abstract file
  • Tables and figures are not allowed;
  • References are not allowed;
  • When abbreviations are used, spell out the full word at first mention in the text followed by the abbreviation in parentheses. Thereafter, use the abbreviation throughout.

 

When the on-line system requires the abstract to be entered, copy and paste your text. In case your text includes special characters (apex, subscript, Greek letters, etc.), please note that they should be inserted through the appropriate buttons which you can find in the online submission system.

Abstracts are limited to 2300 characters, spaces included (title, authors’ names and affiliations excluded). The system will automatically notify you if the abstract exceeds this number of characters.

Title, author(s) and affiliation(s) must be added separately at the appropriate step.

IMPORTANT NOTICE

  • Abstract authors are asked to indicate the most suitable topic for presentation of their work and will also be asked whether they wish apply for an oral presentation during the scientific symposia.

List of topics

  • Accreditation, Patient Safety, Risk management, Quality Assurance, Audit
  • Antimicrobial resistance
  • Artificial intelligence, clinical decision support and machine learning
  • Bone diseases
  • Cardiovascular diseases; risk assessment; cardiac markers
  • Data Science , Digital health, big data and smart technologies
  • Disease specific biomarkers: autoimmune, bone, cardiac, cancer, diabetes,  neurological, sepsis, traumatic brain injury, …
  • Endocrinology
  • Evidence based medicine, including Guidelines
  • Genetic diseases
  • Geriatric testing
  • Green laboratories
  • Hematology
  • Immunology
  • Infectious diseases
  • Kidney diseases and transplantation, urinalysis, urinary biomarkers
  • Laboratory Automation
  • Laboratory Information Systems and globalization of NPU
  • Laboratory Management, Medical leadership
  • Mass Spectrometry
  • Metabolic diseases, diabetes and lipid disorders
  • Metrological traceability and test standardization/harmonization and patient risk
  • Molecular diagnostics, including CTC and ctDNA, cfDNA
  • Neonatal and paediatric laboratory medicine, including prenatal testing
  • Neurodegenerative diseases
  • Nutrition Trace Elements and Vitamins
  • Point of Care testing, critical care, emergency medicine
  • Precision Medicine
  • Protein electrophoresis
  • Reference Intervals: Direct/Indirect; population vs personal reference intervals
  • Test Evaluation,  outcome studies, clinical utility of biomarkers
  • Thrombosis and hemostasis
  • Toxicology and Therapeutic Drug Monitoring
  • Others
The abstract system will be available starting from February 2026.